Hailong Zhang - Healthcare Accounting Supervisor
| 603313 Stock | 6.23 0.13 2.04% |
Executive
Hailong Zhang is Accounting Supervisor of Healthcare Co
| Address | 999 Gaonan Road, Rugao, China, 226521 |
| Phone | 86 513 6816 9482 |
| Web | https://www.hkfoam.com |
Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.0134 % which means that it generated a profit of $0.0134 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0489) %, meaning that it generated substantial loss on money invested by shareholders. Healthcare's management efficiency ratios could be used to measure how well Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At present, Healthcare's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 646.6 M, whereas Intangible Assets are forecasted to decline to about 120.5 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Zhao Wang | Eyebright Medical Technology | 44 | |
| Nan Ding | BrightGene Bio Medical | 34 | |
| Zhong Yiqun | Nanjing Vishee Medical | 55 | |
| Kai Qiu | Nanjing Vishee Medical | 40 | |
| Xia Xue | Luolai Home Textile | 42 | |
| Haifeng Sun | Qumei Furniture Group | 42 | |
| Yuqian Zhou | Eyebright Medical Technology | 38 | |
| Fei Gao | Nanjing Vishee Medical | 39 | |
| Yongli Ma | Hebei Yangyuan ZhiHui | 49 | |
| Fang Liu | BrightGene Bio Medical | N/A | |
| Zhengye Wang | BrightGene Bio Medical | 54 | |
| Zhang Hui | Nanjing Vishee Medical | 44 | |
| Kai Li | BrightGene Bio Medical | 49 | |
| Wu Xia | Nanjing Vishee Medical | 43 | |
| He Huang | Nanjing Vishee Medical | 51 | |
Management Performance
| Return On Equity | -0.0489 | ||||
| Return On Asset | 0.0134 |
Healthcare Leadership Team
Elected by the shareholders, the Healthcare's board of directors comprises two types of representatives: Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Healthcare. The board's role is to monitor Healthcare's management team and ensure that shareholders' interests are well served. Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zhen Wang, Director VP | ||
| Xiao Wu, VP Director | ||
| Zhang Jian, VP Director | ||
| Hailong Zhang, Accounting Supervisor | ||
| Zhang Ni, Chairman President | ||
| Xinlong Fan, VP | ||
| Hong Zhang, VP Director |
Healthcare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0489 | ||||
| Return On Asset | 0.0134 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 6.59 B | ||||
| Shares Outstanding | 570.59 M | ||||
| Shares Owned By Insiders | 43.35 % | ||||
| Shares Owned By Institutions | 14.48 % | ||||
| Price To Book | 0.97 X | ||||
| Price To Sales | 0.43 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Healthcare Stock
Healthcare financial ratios help investors to determine whether Healthcare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Healthcare with respect to the benefits of owning Healthcare security.